8-47737855-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005195.4(CEBPD):āc.266A>Gā(p.Asn89Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000683 in 1,493,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005195.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEBPD | NM_005195.4 | c.266A>G | p.Asn89Ser | missense_variant | 1/1 | ENST00000408965.4 | NP_005186.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEBPD | ENST00000408965.4 | c.266A>G | p.Asn89Ser | missense_variant | 1/1 | NM_005195.4 | ENSP00000386165 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000865 AC: 13AN: 150224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 4AN: 166278Hom.: 0 AF XY: 0.0000318 AC XY: 3AN XY: 94484
GnomAD4 exome AF: 0.0000663 AC: 89AN: 1343322Hom.: 0 Cov.: 31 AF XY: 0.0000644 AC XY: 43AN XY: 668180
GnomAD4 genome AF: 0.0000865 AC: 13AN: 150224Hom.: 0 Cov.: 32 AF XY: 0.0000409 AC XY: 3AN XY: 73292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.266A>G (p.N89S) alteration is located in exon 1 (coding exon 1) of the CEBPD gene. This alteration results from a A to G substitution at nucleotide position 266, causing the asparagine (N) at amino acid position 89 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at